M
3723
The drug's manufacturer, Eli Lilly, has engaged with the HSE in recent months to discuss pricing offers, and Professor Michael Barry from the National Centre for Pharmacoeconomics said the discounted price could make the drug a cost-effective investment. #Mounjaro #HSE #WeightLoss
HSE in talks to cover Mounjaro weight-loss drug for over one million Irish patients
www.rsvplive.ie